Skip to main content

Advertisement

SpringerLink
Log in

Alzheimer’s disease and cancer: the need of putting research into context with previous published systematic reviews

  • Letter to the Editor
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

The Original Article was published on 12 July 2014

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Catalá-López F, Suárez-Pinilla M, Suárez-Pinilla P, Valderas JM, Gómez-Beneyto M, Martinez S, Balanzá-Martínez V, Climent J, Valencia A, McGrath J, Crespo-Facorro B, Sanchez-Moreno J, Vieta E, Tabarés-Seisdedos R (2014a) Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom 83(2):89–105

    Article  PubMed  Google Scholar 

  • Catalá-López F, Crespo-Facorro B, Vieta E, Valderas JM, Valencia A, Tabarés-Seisdedos R (2014b) Alzheimer’s disease and cancer: current epidemiological evidence for a mutual protection. Neuroepidemiology 42(2):121–122

    Article  PubMed  Google Scholar 

  • Chalmers I, Hedges LV, Cooper H (2002) A brief history of research synthesis. Eval Health Prof 25:12–37

    Article  PubMed  Google Scholar 

  • Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, Howells DW, Ioannidis JP, Oliver S (2014) How to increase value and reduce waste when research priorities are set. Lancet 383(9912):156–165

    Article  PubMed  Google Scholar 

  • Clarke M, Hopewell S, Chalmers I (2007) Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report. J R Soc Med 100:187–190

    Article  PubMed Central  PubMed  Google Scholar 

  • Clarke M, Hopewell S, Chalmers I (2010) Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet 376:20–21

    Article  PubMed  Google Scholar 

  • Ibáñez K, Boullosa C, Tabarés-Seisdedos R, Baudot A, Valencia A (2014) Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses. PLoS Genet 10(2):e1004173

    Article  PubMed Central  PubMed  Google Scholar 

  • Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R (2014) Increasing value and reducing waste in research design, conduct, and analysis. Lancet 383(9912):166–175

    Article  PubMed  Google Scholar 

  • Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioannidis JP, Al-Shahi Salman R, Chan AW, Glasziou P (2014) Biomedical research: increasing value, reducing waste. Lancet 383(9912):101–104

    Article  PubMed  Google Scholar 

  • Moher D (2013) The problem of duplicate systematic reviews. BMJ 347:f5040

    Article  PubMed  Google Scholar 

  • Shi HB, Tang B, Liu YW, Wang XF, Chen GJ (2014) Alzheimer disease and cancer risk: a meta-analysis. J Cancer Res Clin Oncol.http://www.ncbi.nlm.nih.gov/pubmed/25015770

  • Siontis KC, Hernandez-Boussard T, Ioannidis JP (2013) Overlapping meta-analyses on the same topic: survey of published studies. BMJ 347:f4501

    Article  PubMed Central  PubMed  Google Scholar 

  • Tabarés-Seisdedos R, Rubenstein JL (2013) Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders. Nat Rev Neurosci 14:293–304

    Article  PubMed  Google Scholar 

  • Tabarés-Seisdedos R, Dumont N, Baudot A, Valderas JM, Climent J, Valencia A, Crespo-Facorro B, Vieta E, Gómez-Beneyto M, Martínez S, Rubenstein JL (2011) No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet Oncol 12:604–608

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Medicines and Healthcare Products Agency (AEMPS), Campezo, 1 Edificio 8, 28022, Madrid, Spain

    Ferrán Catalá-López

  2. Fundación Instituto Investigación de Servicios en Salud, Valencia, Spain

    Ferrán Catalá-López

  3. Department of Medicine, University of Valencia, CIBERSAM, INCLIVA, Valencia, Spain

    Rafael Tabarés-Seisdedos

Authors
  1. Ferrán Catalá-López
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rafael Tabarés-Seisdedos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ferrán Catalá-López.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Catalá-López, F., Tabarés-Seisdedos, R. Alzheimer’s disease and cancer: the need of putting research into context with previous published systematic reviews. J Cancer Res Clin Oncol 141, 569–570 (2015). https://doi.org/10.1007/s00432-014-1805-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-014-1805-1

Keywords

Search

Navigation